Cosmetic Claims in Creator Content: When They Become Drug Claims

Beauty content crosses into drug territory when its intended-use claims say a product treats or prevents disease or affects the structure or function of the body. Separately, every objective advertising claim needs adequate support. Review both questions: FDA classification and labeling on one side, FTC advertising truthfulness and substantiation on the other.

Flag language that changes intended use

The FDA's Cosmetics Labeling Claims guidance explains that cosmetics generally do not receive premarket claim approval, but their labeling must be truthful and not misleading. A product marketed to treat or prevent disease, or to affect body structure or function including skin, is a drug under federal law and must meet drug requirements.

Common review flags include claims that a cosmetic:

• Treats acne, eczema, rosacea, infection, or another disease
• Rebuilds collagen or changes cellular function
• Permanently alters hair growth or pigmentation
• Heals tissue or reduces inflammation in a disease context
• Replaces a prescription, procedure, or medical treatment

Context matters. “Makes skin look smoother” differs from “restructures damaged skin.” A creator's images, product name, hashtags, and demonstrations can reinforce an intended-use message even when the script avoids an explicit disease verb.

Keep FDA classification and FTC evidence separate

The FTC's Health Products Compliance Guidance addresses advertising substantiation. Health-related efficacy and safety claims generally need competent and reliable scientific evidence appropriate to the claim. FDA compliance does not automatically prove an ad is substantiated, and an FTC-compliant disclosure does not resolve drug classification.

For each claim, record:

1. The exact words, images, and implied message
2. Whether the message concerns appearance, disease, or body structure/function
3. The marketed product and intended-use materials
4. The evidence supporting the finished product under advertised conditions
5. Required label or drug status reviewed by regulatory counsel
6. The generally expected result communicated by any testimonial

Route ambiguous claims to qualified regulatory counsel. A reviewer should not improvise the line between cosmetic and drug during launch hour.

Give creators an approved vocabulary with boundaries

A usable claim library pairs allowed language with prohibited extensions and required context. For example:

| Approved direction | Escalate before use | |:---|:---| | “Skin looks more hydrated” | “Repairs the skin barrier permanently” | | “Temporarily reduces the appearance of fine lines” | “Reverses skin aging” | | “Helps makeup apply smoothly” | “Treats eczema-related texture” | | “Hair looks fuller” | “Regrows hair” |

These are screening examples, not universal safe harbors. Evidence, formulation, consumer interpretation, and full context control. Do not teach creators to swap one verb mechanically while leaving images that communicate the prohibited message.

Use the sponsored-video review checklist for the final asset and the testimonial substantiation guide when personal results become the campaign proof.

Check demonstrations and before-and-after imagery

Beauty content is highly visual. Lighting, makeup, filters, camera settings, timing, styling, and concurrent treatments can create or amplify apparent effects. Preserve originals and review edits.

Ask:

• Was the advertised product the only material intervention?
• Is the timeline accurate and visible?
• Does the result reflect ordinary use?
• Were images retouched or generated?
• Does a temporary optical effect look like a physiological change?
• Does the model's statement imply typical consumer performance?

A tiny “results vary” note does not cure a visual that communicates unsupported dramatic results. Remove or redesign a claim when the evidence cannot support the net impression.

Work through category edge cases

Acne makeup. Covering the appearance of acne may be cosmetic; claiming to treat acne is a drug claim.

SPF moisturizer. Sunscreen claims involve over-the-counter drug requirements in the United States, even when the product is marketed as a cosmetic moisturizer.

Anti-dandruff shampoo. Cleansing or beautifying hair is cosmetic; treating dandruff invokes drug status.

Device plus serum. A beauty device can introduce medical-device questions, and evidence for the serum alone may not support combined performance.

Creator paraphrases packaging. Label copy can still be misquoted or expanded into a stronger advertising message. Approve actual creator language.

International reuse. Cosmetic and therapeutic classifications differ by market. A U.S. review does not authorize translation and global distribution.

Build a two-track approval record

Keep the final content, transcript, claim map, substantiation, product label, intended-use assessment, originals, and reviewer signoff. Identify whether each finding is an FDA classification issue, an FTC support issue, a testimonial issue, or a brand preference. That precision produces usable feedback and a better audit trail.

Reopen current FDA and FTC guidance immediately before publication and when the formula, label, target market, or creative changes.

General U.S.-focused information only, not legal or regulatory advice. Product classification and substantiation require qualified counsel and scientific expertise.